<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00319007</url>
  </required_header>
  <id_info>
    <org_study_id>23266</org_study_id>
    <secondary_id>KUN 2003-2911</secondary_id>
    <nct_id>NCT00319007</nct_id>
  </id_info>
  <brief_title>Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis</brief_title>
  <official_title>Adenoma-Carcinoma Sequence in the Ileal Pouch Anal Anastomosis in Patients With Familial Adenomatous Polyposis: Studies on Luminal and Mucosal Risk Factors and Chemoprevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether sulindac and VSL#3 - inulin, either
      combined or alone, are effective in treating or preventing adenoma development in the ileal
      anal pouch in patients with familial adenomatous polyposis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2006</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pouch mucosal proliferation index at 0, 1 and 2 months</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Pouch mucosal apoptosis index at 0, 1 and 2 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pouch mucosal Glutathione S transferases activity and isoenzyme levels at 0, 1 and 2 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal genotoxicity at 0, 1 and 2 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal cytotoxicity at 0, 1 and 2 months</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Adenomatous Polyposis Coli</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sulindac (drug)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VSL#3 (probiotic)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inulin (probiotic)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically or genetically proven familial adenomatous polyposis

          -  Restorative proctocolectomy with ileal pouch anal anastomosis

        Exclusion Criteria:

          -  Chronic or acute renal or hepatic disease

          -  History of oesophageal, gastric or duodenal ulcers

          -  Known hypersensitivity to sulindac

          -  Daily use during the last three months of:

          -  Aspirin

          -  Non-Steroidal Anti-Inflammatory Agents

          -  Probiotics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fokko M Nagengast, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pieter Friederich, MD</last_name>
    <phone>00-31-24-3614760</phone>
    <email>P.Friederich@mdl.umcn.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fokko M Nagengast, PhD</last_name>
    <phone>00-31-24-3614760</phone>
    <email>F.Nagengast@mdl.umcn.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6533DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Friederich, MD</last_name>
      <phone>00-31-24-3614760</phone>
      <email>P.Friederich@mdl.umcn.nl</email>
    </contact>
    <contact_backup>
      <last_name>Fokko M Nagengast, PhD</last_name>
      <phone>00-31-24-3504066</phone>
      <email>F.Nagengast@mdl.umcn.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Pieter P Friederich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2006</study_first_submitted>
  <study_first_submitted_qc>April 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2006</study_first_posted>
  <last_update_submitted>August 9, 2007</last_update_submitted>
  <last_update_submitted_qc>August 9, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
    <mesh_term>Adenomatous Polyposis Coli</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulindac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

